Patient Guide: A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 53 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04817007
Status: ACTIVE_NOT_RECRUITING
Condition: Myelofibrosis
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 53 locations across the country.

Top locations include:
  • • Newport Beach, California
  • • Lake Mary, Florida
  • • New Orleans, Louisiana
  • • And 50 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis) - Join Clinical Trial NCTNCT04817007

How to Join This Clinical Trial - NCTNCT04817007

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Myelofibrosis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myelofibrosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myelofibrosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04817007 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 53 locations. Find a study site near you:

Clinical Research Site

Newport Beach, California 92663 - United States

Status: Contact for availability

Clinical Research Site

Lake Mary, Florida 32746 - United States

Status: Contact for availability

Clinical Research Site

New Orleans, Louisiana 70112 - United States

Status: Contact for availability

Clinical Research Site

Worcester, Massachusetts 01655 - United States

Status: Contact for availability

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: Contact for availability

Clinical Research Site

Hackensack, New Jersey 07601 - United States

Status: Contact for availability

Clinical Research Site

Chapel Hill, North Carolina 27514 - United States

Status: Contact for availability

Clinical Research Site

Pittsburgh, Pennsylvania 15224 - United States

Status: Contact for availability

Clinical Research Site

Blacktown, New South Wales 2148 - Australia

Status: Contact for availability

Clinical Research Site

Wollongong, New South Wales 2500 - Australia

Status: Contact for availability

And 43 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Myelofibrosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships